Syngulon SA
Ouverture de faillite 9.0 FTESyngulon reported total assets of €5.66m at the end of the 2023 financial year (annual accounts filed with the NBB on 19 Jul 2024), with 9 full-time equivalents.
By total assets for 2023, Syngulon ranks among the 200 largest of the 895 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Syngulon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Equity -25 % Total assets +2 % Headcount (avg FTE) +12 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Syngulon's annual accounts
Filed annual accounts
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
- Year ended 31 Dec 2020filed on 15 Jul 2021
- Year ended 31 Dec 2019filed on 29 Jun 2020
Syngulon's financial analysis
- Solvency44.6%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Syngulon
Syngulon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0521.816.349
- VAT number
- BE0521816349
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 07 Mar 2013
- Registered office
- 4102 Seraing
- Size
- Micro · 9.0 FTE
- Latest accounts
- 2023 · filed on 19 Jul 2024
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Syngulon (SA) has been based in Seraing since 2013, active in: research and experimental development on biotechnology. For 2023, it reports a net loss of 720,764 € and equity of €2.52m; its revenue is not published. With 9.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 44.6%, below the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Syngulon
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- BioKuris Research and experimental development on natural sciences and engineering Herstal · balance sheet €5.85m
- Hebrimo Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €4.71m
- Orionis Biosciences Research and experimental development on natural sciences and engineering Ghent · balance sheet €6.88m
- CM4Cure Research and experimental development on natural sciences and engineering Liège · balance sheet €4.57m
- Cryoport Belgium Research and experimental development on natural sciences and engineering Villers-le-Bouillet · balance sheet €16.2m
- HepaVue Dx Research and experimental development on natural sciences and engineering Waterloo · balance sheet €3.71m
- Envitec Measurements and Analytics SA Research and experimental development on natural sciences and engineering Gembloux · balance sheet €3.64m
Frequently asked questions about Syngulon
What is the revenue of Syngulon?
Syngulon files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of Syngulon?
In Belgium, the VAT number is the company number prefixed with BE: BE0521816349 for Syngulon, if the company is VAT-registered. Its company number (CBE) is 0521.816.349.
Where is the registered office of Syngulon?
According to the CBE register, the registered office of Syngulon is in 4102 Seraing.
What is the equity of Syngulon?
At the close of the 2023 financial year, the equity of Syngulon amounts to 2,524,757 €, a solvency of 44.6% of total assets.
How many people work at Syngulon?
9.0 full-time equivalents on average according to the 2023 social balance sheet.
Who manages Syngulon?
The register lists 8 active mandates at Syngulon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Syngulon within its sector?
By total assets for 2023, Syngulon ranks among the 200 largest of the 895 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Syngulon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →